Genomic Mosaicism in Colorectal Cancer and Polyposis Syndromes
Author Information
Author(s): de Moraes Francisco Cezar Aquino, Moretti Nayara Rozalem, Sano Vitor Kendi Tsuchiya, Ngan Cristiane Wen Tsing, Burbano Rommel Mario Rodríguez
Primary Institution: Federal University of Pará, Belém, Pará, Brazil
Hypothesis
This study aimed to investigate the prevalence and impact of somatic mosaicism in colorectal cancer and polyposis syndromes.
Conclusion
The study found that mosaicism is a critical factor in colorectal cancer susceptibility and should be included in routine genetic testing for at-risk patients.
Supporting Evidence
- The overall prevalence of somatic mosaicism was found to be 8.79%.
- Patients with APC mutations showed a significantly higher prevalence of mosaicism at 13.43%.
- MLH1 and MSH2 mosaicism were observed at rates of 2.75% and 9.69%, respectively.
Takeaway
Some people with colorectal cancer have a mix of different genetic cells, which can affect their disease. This study shows that checking for these mixed cells can help doctors better understand and treat patients.
Methodology
A systematic review and meta-analysis were conducted using data from PubMed, Scopus, and Web of Science to evaluate mosaicism in patients with colorectal cancer or polyposis syndromes.
Potential Biases
Potential publication bias was indicated by the asymmetrical distribution in the funnel plot.
Limitations
The study faced significant heterogeneity among included studies, which may affect the reliability of the prevalence estimates.
Participant Demographics
The analysis included 2272 patients from 27 studies, with a focus on those diagnosed with colorectal cancer or polyposis syndromes.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI 5.1 to 14.70%
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website